Streetbeat News

Price Targets

APTV

BWA

GM

GNTX

MGA

RACE

TSLA

Bank of America Securities analyst John Murphy has upgraded the stock ratings of auto suppliers Aptiv, BorgWarner, Gentex, and Magna International, and raised their price targets. He also increased the price targets for Tesla, General Motors, and Ferrari. Murphy's upgrades are based on improving industry dynamics, with supplier estimates 5%-10% above consensus over 2023 to 2025. He expects strong 2Q23 results and higher 2023 outlooks, particularly from suppliers.

Portfolio Pulse from Anusuya Lahiri

July 06, 2023 | 3:41 pm

CSIQ

UBS analyst Jon Windham has upgraded Canadian Solar Inc (NASDAQ:CSIQ) from Neutral to Buy, raising the price target from $48 to $50. The company's Recurrent Energy solar and storage project development business is expected to generate 41% YoY revenue growth in 2023. The growth is supported by an acceleration in U.S. utility scale solar installations. Canadian Solar is also set to benefit from Inflation Reduction Act incentives through its Recurrent Energy development business and planned 5GW module assembly facility in Texas.

Portfolio Pulse from Priya Nigam

July 06, 2023 | 3:06 pm

RXO

In the last quarter, RXO (NYSE:RXO) received one somewhat bullish rating and three indifferent ratings from analysts. Over the past three months, four analysts have offered 12-month price targets for RXO, with an average price target of $22.0, a high of $27.00, and a low of $20.00. The average price target has increased by 4.76% over the past month.

Portfolio Pulse from Benzinga Insights

July 06, 2023 | 3:01 pm

HLLY

Canaccord Genuity has maintained a Buy rating on Holley's stock and increased its price target from $5 to $6, leading to a rise in Holley's shares.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 2:58 pm

T

Barclays analyst Kannan Venkateshwar has maintained an Equal-Weight rating on AT&T (NYSE:T) and lowered the price target from $18 to $17.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 2:51 pm

SAVA

HC Wainwright & Co. analyst Vernon Bernardino has reiterated a 'Buy' rating on Cassava Sciences (NASDAQ:SAVA) and maintained a price target of $124.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 2:49 pm

CCCC

Brookline Capital has issued a note stating that the FDA-clearance of IND supports their outlook that C4 Therapeutics' CFT8634 could enter the third-line NSCLC market and could have sales of $1.1 billion. They have given C4 Therapeutics a buy rating and a price target of $84.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 2:41 pm

UVE

Piper Sandler analyst Paul Newsome maintains an Overweight rating on Universal Insurance Hldgs (NYSE:UVE) but lowers the price target from $23 to $22.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 2:33 pm

UFCS

Piper Sandler analyst Paul Newsome has maintained an 'Underweight' rating on United Fire Gr (NASDAQ:UFCS) and lowered the price target from $26 to $22.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 2:33 pm

TRV

Piper Sandler analyst Paul Newsome maintains a Neutral rating on Travelers Companies (NYSE:TRV) and lowers the price target from $208 to $176.

Portfolio Pulse from richadhand@benzinga.com

July 06, 2023 | 2:22 pm